期刊
NATURE CELL BIOLOGY
卷 11, 期 3, 页码 320-U204出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/ncb1840
关键词
-
类别
资金
- Centers of Excellence Grant in Molecular Haematology
- National Institutes of Health
- American Cancer Society
Cancer cells frequently undergo a shift from oxidative to glycolytic metabolism(1). Although there is interest in targeting metabolism as a form of cancer therapy, this area still remains in its infancy. Using cells, embryos and adult animals, we show here that loss of the widely expressed transcription factor Oct1 induces a coordinated metabolic shift: mitochondrial activity and amino acid oxidation are increased, while glucose metabolism is reduced. Altered expression of direct Oct1 targets encoding metabolic regulators provides a mechanistic underpinning to these results. We show that these metabolic changes directly oppose tumorigenicity. Collectively, our findings show that Oct1, the genes it regulates and the pathways these genes affect could be used as targets for new modes of cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据